Literature DB >> 21976650

Spring-loaded model revisited: paramyxovirus fusion requires engagement of a receptor binding protein beyond initial triggering of the fusion protein.

Matteo Porotto1, Ilaria Devito, Samantha G Palmer, Eric M Jurgens, Jia L Yee, Christine C Yokoyama, Antonello Pessi, Anne Moscona.   

Abstract

During paramyxovirus entry into a host cell, receptor engagement by a specialized binding protein triggers conformational changes in the adjacent fusion protein (F), leading to fusion between the viral and cell membranes. According to the existing paradigm of paramyxovirus membrane fusion, the initial activation of F by the receptor binding protein sets off a spring-loaded mechanism whereby the F protein progresses independently through the subsequent steps in the fusion process, ending in membrane merger. For human parainfluenza virus type 3 (HPIV3), the receptor binding protein (hemagglutinin-neuraminidase [HN]) has three functions: receptor binding, receptor cleaving, and activating F. We report that continuous receptor engagement by HN activates F to advance through the series of structural rearrangements required for fusion. In contrast to the prevailing model, the role of HN-receptor engagement in the fusion process is required beyond an initiating step, i.e., it is still required even after the insertion of the fusion peptide into the target cell membrane, enabling F to mediate membrane merger. We also report that for Nipah virus, whose receptor binding protein has no receptor-cleaving activity, the continuous stimulation of the F protein by a receptor-engaged binding protein is key for fusion. We suggest a general model for paramyxovirus fusion activation in which receptor engagement plays an active role in F activation, and the continued engagement of the receptor binding protein is essential to F protein function until the onset of membrane merger. This model has broad implications for the mechanism of paramyxovirus fusion and for strategies to prevent viral entry.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21976650      PMCID: PMC3233114          DOI: 10.1128/JVI.05873-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  82 in total

1.  Amino acid substitutions in a conserved region in the stalk of the Newcastle disease virus HN glycoprotein spike impair its neuraminidase activity in the globular domain.

Authors:  Z Wang; R M Iorio
Journal:  J Gen Virol       Date:  1999-03       Impact factor: 3.891

2.  Enfuvirtide, a new drug for HIV infection.

Authors:  Courtney V Fletcher
Journal:  Lancet       Date:  2003-05-10       Impact factor: 79.321

3.  Simultaneous visualization of multiple protein interactions in living cells using multicolor fluorescence complementation analysis.

Authors:  Chang-Deng Hu; Tom K Kerppola
Journal:  Nat Biotechnol       Date:  2003-04-14       Impact factor: 54.908

4.  Structure-based identification of an inducer of the low-pH conformational change in the influenza virus hemagglutinin: irreversible inhibition of infectivity.

Authors:  L R Hoffman; I D Kuntz; J M White
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

5.  Paramyxovirus receptor-binding molecules: engagement of one site on the hemagglutinin-neuraminidase protein modulates activity at the second site.

Authors:  Matteo Porotto; Micaela Fornabaio; Olga Greengard; Matthew T Murrell; Glen E Kellogg; Anne Moscona
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

6.  Kinetic dependence of paramyxovirus entry inhibition.

Authors:  Matteo Porotto; Christine C Yokoyama; Gianmarco Orefice; Han-Sung Kim; Mohamed Aljofan; Bruce A Mungall; Anne Moscona
Journal:  J Virol       Date:  2009-04-15       Impact factor: 5.103

7.  Soluble respiratory syncytial virus fusion protein in the fully cleaved, pretriggered state is triggered by exposure to low-molarity buffer.

Authors:  Supranee Chaiwatpongsakorn; Raquel F Epand; Peter L Collins; Richard M Epand; Mark E Peeples
Journal:  J Virol       Date:  2011-02-09       Impact factor: 5.103

8.  Bimolecular complementation of paramyxovirus fusion and hemagglutinin-neuraminidase proteins enhances fusion: implications for the mechanism of fusion triggering.

Authors:  Sarah A Connolly; George P Leser; Theodore S Jardetzky; Robert A Lamb
Journal:  J Virol       Date:  2009-08-26       Impact factor: 5.103

9.  Human parainfluenza virus infection of the airway epithelium: viral hemagglutinin-neuraminidase regulates fusion protein activation and modulates infectivity.

Authors:  Laura M Palermo; Matteo Porotto; Christine C Yokoyama; Samantha G Palmer; Bruce A Mungall; Olga Greengard; Stefan Niewiesk; Anne Moscona
Journal:  J Virol       Date:  2009-04-22       Impact factor: 5.103

10.  A dual-functional paramyxovirus F protein regulatory switch segment: activation and membrane fusion.

Authors:  Charles J Russell; Karen L Kantor; Theodore S Jardetzky; Robert A Lamb
Journal:  J Cell Biol       Date:  2003-10-27       Impact factor: 10.539

View more
  32 in total

1.  Mechanism for active membrane fusion triggering by morbillivirus attachment protein.

Authors:  Nadine Ader; Melinda Brindley; Mislay Avila; Claes Örvell; Branka Horvat; Georg Hiltensperger; Jürgen Schneider-Schaulies; Marc Vandevelde; Andreas Zurbriggen; Richard K Plemper; Philippe Plattet
Journal:  J Virol       Date:  2012-10-17       Impact factor: 5.103

2.  Fusion activation by a headless parainfluenza virus 5 hemagglutinin-neuraminidase stalk suggests a modular mechanism for triggering.

Authors:  Sayantan Bose; Aarohi Zokarkar; Brett D Welch; George P Leser; Theodore S Jardetzky; Robert A Lamb
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-04       Impact factor: 11.205

3.  Regulation of paramyxovirus fusion activation: the hemagglutinin-neuraminidase protein stabilizes the fusion protein in a pretriggered state.

Authors:  Matteo Porotto; Zuhair W Salah; Long Gui; Ilaria DeVito; Eric M Jurgens; Hong Lu; Christine C Yokoyama; Laura M Palermo; Kelly K Lee; Anne Moscona
Journal:  J Virol       Date:  2012-09-19       Impact factor: 5.103

4.  Fusion activation through attachment protein stalk domains indicates a conserved core mechanism of paramyxovirus entry into cells.

Authors:  Sayantan Bose; Albert S Song; Theodore S Jardetzky; Robert A Lamb
Journal:  J Virol       Date:  2014-01-22       Impact factor: 5.103

5.  The second receptor binding site of the globular head of the Newcastle disease virus hemagglutinin-neuraminidase activates the stalk of multiple paramyxovirus receptor binding proteins to trigger fusion.

Authors:  Matteo Porotto; Zuhair Salah; Ilaria DeVito; Aparna Talekar; Samantha G Palmer; Rui Xu; Ian A Wilson; Anne Moscona
Journal:  J Virol       Date:  2012-03-21       Impact factor: 5.103

6.  Triggering the measles virus membrane fusion machinery.

Authors:  Melinda A Brindley; Makoto Takeda; Philippe Plattet; Richard K Plemper
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-01       Impact factor: 11.205

7.  Mechanism of fusion triggering by human parainfluenza virus type III: communication between viral glycoproteins during entry.

Authors:  Matteo Porotto; Samantha G Palmer; Laura M Palermo; Anne Moscona
Journal:  J Biol Chem       Date:  2011-11-22       Impact factor: 5.157

8.  Identification of a region in the stalk domain of the nipah virus receptor binding protein that is critical for fusion activation.

Authors:  Aparna Talekar; Ilaria DeVito; Zuhair Salah; Samantha G Palmer; Anasuya Chattopadhyay; John K Rose; Rui Xu; Ian A Wilson; Anne Moscona; Matteo Porotto
Journal:  J Virol       Date:  2013-07-31       Impact factor: 5.103

9.  Individual N-glycans added at intervals along the stalk of the Nipah virus G protein prevent fusion but do not block the interaction with the homologous F protein.

Authors:  Qiyun Zhu; Scott B Biering; Anne M Mirza; Brittany A Grasseschi; Paul J Mahon; Benhur Lee; Hector C Aguilar; Ronald M Iorio
Journal:  J Virol       Date:  2013-01-02       Impact factor: 5.103

10.  Measles virus fusion machinery activated by sialic acid binding globular domain.

Authors:  Aparna Talekar; Anne Moscona; Matteo Porotto
Journal:  J Virol       Date:  2013-10-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.